FMIUX
Price
$37.26
Change
+$0.04 (+0.11%)
Updated
Dec 23 closing price
VIMAX
Price
$330.34
Change
-$1.55 (-0.47%)
Updated
Dec 23 closing price
Ad is loading...

FMIUX vs VIMAX

Header iconFMIUX vs VIMAX Comparison
Open Charts FMIUX vs VIMAXBanner chart's image
FMI Common Stock Institutional
Price$37.26
Change+$0.04 (+0.11%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Admiral
Price$330.34
Change-$1.55 (-0.47%)
VolumeN/A
CapitalizationN/A
FMIUX vs VIMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FMIUX vs. VIMAX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMIUX is a Hold and VIMAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 190B vs. FMIUX (2.17B). VIMAX pays higher dividends than FMIUX: VIMAX (1.49) vs FMIUX (0.32). FMIUX was incepted earlier than VIMAX: FMIUX (8 years) vs VIMAX (23 years). FMIUX is a more actively managed with annual turnover of: 23.00 vs. VIMAX (13.00). VIMAX has a lower initial minimum investment than FMIUX: VIMAX (3000) vs FMIUX (100000). VIMAX annual gain was more profitable for investors over the last year : 15.92 vs. FMIUX (9.22). VIMAX return over 5 years is better than : 52.16 vs. FMIUX (44.19).
FMIUXVIMAXFMIUX / VIMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years23 years-
Gain YTD9.37915.37961%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets2.17B190B1%
Annual Yield % from dividends0.321.4922%
Returns for 1 year9.2215.9258%
Returns for 3 years20.286.98291%
Returns for 5 years44.1952.1685%
Returns for 10 yearsN/A118.50-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AQN4.480.09
+2.05%
Algonquin Power & Utilities Corp
XYL117.510.37
+0.32%
Xylem
DRUG38.690.04
+0.10%
Bright Minds Biosciences
ARDX4.58-0.24
-4.98%
Ardelyx
GDTC2.37-0.19
-7.42%
CytoMed Therapeutics Limited